Meridian Bioscience Inc.
Active in EUDAMEDUnited Statesfrom SRN EUDAMED SRN US-MF-000044096
Meridian Bioscience Inc. is a medical device manufacturer based in the United States, with 246 devices listed in 4 registries (FDA Class I, II and III; EU Class A) and 22 FDA recalls as of 18 Nov 2026.
- Devices
- 246
- Registrations
- EUDAMED
- FDA recalls
- 229 ongoing
Registry facts
- Registries
- FDA GUDID 207
- FDA 510(k) 35
- EUDAMED 30
- FDA PMA 1
- Device classes
- FDA Class I 162
- FDA Class II 62
- EU Class A 16
- FDA Class III 3
- EU Class C 2
- Top EMDN categories
- FDA recalls
- Sites and related companies
- Meridian Bioscience, Inc. United States
- Identifiers
- EUDAMED SRN US-MF-000044096
- DUNS 092815364
At a glance
Market reach
- European Union
- EUDAMED actor
- United States
- FDA recalls
What Meridian Bioscience Inc. makes
Meridian Bioscience Inc. manufactures in vitro diagnostic (IVD) kits and reagents for nucleic acid extraction and isolation, including DNA sample preparation systems and related consumables. Products include the M-prep DNA Sample Preparation Kit, Revogene Check assays, and Para-Pak series tubes, caps, and solvents designed for sample processing and purification.
These devices are classified as Class A under EU regulations and are listed in the EUDAMED database. The company is based in the United States.
Catalogue
Search and filter all 246 devicesShowing 1-50 of 246
Company details
- EUDAMED SRN
- US-MF-000044096
- DUNS number
- 092815364
- EUDAMED status
- Active
- EUDAMED registered name
- Meridian Bioscience Inc.
- EUDAMED abbreviated name
- MBI Inc.
- Registered address
- 3471, River Hills Drive, 45244, Cincinnati (OHIO), United States
- Website
- www.meridianbioscience.com/
- facebook.com/MeridianBioscience
- Phone
- +1 513.673.8109
- PRRC contact
- Susan Bogar
FDA recalls
Recalls initiated per year
- 2017 0
- 2018 1
- 2019 0
- 2020 0
- 2021 3
- 2022 3
- 2023 3
- 2024 0
- 2025 3
- 2026 0
2025
- 5 Dec 2025 Z-1019-2026 Class II Ongoing The affected lots show a decline in performance over time, which may lead to false-negative results.
- 7 Oct 2025 Z-0568-2026 Class II Ongoing The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
Full distribution text
- 7 Oct 2025 Z-0569-2026 Class II Ongoing The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.
Full distribution text
2023
- 19 Oct 2023 Z-0519-2024 Class II Ongoing Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.
- 19 Oct 2023 Z-0520-2024 Class II Ongoing Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.
- 19 Oct 2023 Z-0521-2024 Class II Ongoing Due to a manufacturing defect, certain Para-Pak vials may be at risk for leakage.
2022
- 15 Dec 2022 Z-1008-2023 Class II Ongoing Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2
- 22 Jun 2022 Z-1479-2022 Class II Ongoing When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the cooling period, exposing the user to heated instrument components. Incidental contact with heated instrument components may result in an injury such as minor burns.
- 15 Feb 2022 Z-0836-2022 Class II Ongoing The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.
Full distribution text
2021
- 8 Apr 2021 Z-1540-2021 Class II Terminated Emergency Use Application (EUA) application withdrawn as false negative results reported
Show all 22 recalls
2021
- 8 Apr 2021 Z-1541-2021 Class II Terminated Emergency Use Application (EUA) application withdrawn as false negative results reported
- 8 Feb 2021 Z-1299-2021 Class II Terminated Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.
2018
- 17 Dec 2018 Z-0732-2019 Class II Terminated An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.
Full distribution text
- 17 Dec 2018 Z-0732-2019 Class II Terminated An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.
2016
- 8 Nov 2016 Z-1033-2017 Class II Terminated Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.
Full distribution text
- 8 Nov 2016 Z-1033-2017 Class II Terminated Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.
2014
- 22 Apr 2014 Z-1941-2014 Class II Terminated Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.
Full distribution text
- 22 Apr 2014 Z-1941-2014 Class II Terminated Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.
2011
- 10 Oct 2011 Z-0203-2012 Unclassified (pre-2012) Terminated Internal testing has shown that the indicated kits produce false negative results when tested with some direct stool specimens. These false negative reactions are not observed for all devices tested, however, the rate of occurrence will likely impact clinical sensitivity as defined by product registration and associated instructions for use.
Full distribution text
- 10 Oct 2011 Z-0203-2012 Unclassified (pre-2012) Terminated Internal testing has shown that the indicated kits produce false negative results when tested with some direct stool specimens. These false negative reactions are not observed for all devices tested, however, the rate of occurrence will likely impact clinical sensitivity as defined by product registration and associated instructions for use.
2006
- 2 Jun 2006 Z-1203-06 Unclassified (pre-2012) Terminated The product may produce non-specific reactions with negative specimens and/or the negative control reagent. These non-specific interactions may result in increased invalid test rates and/or positivity rates.
2003
- 23 Sep 2003 Z-0062-04 Unclassified (pre-2012) Terminated The kits were packaged with incorrect dispensing pipettes.
Full distribution text
- 18 Jun 2003 Z-1127-03 Unclassified (pre-2012) Terminated The Low Positive Standard kit component is losing potency that may result in false positive test results.
- 23 Sep 2003 Z-0062-04 Unclassified (pre-2012) Terminated The kits were packaged with incorrect dispensing pipettes.
2002
- 26 Dec 2002 Z-0463-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.
Full distribution text
- 26 Dec 2002 Z-0464-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.
Full distribution text
- 26 Dec 2002 Z-0465-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.
Full distribution text
- 26 Dec 2002 Z-0463-03 Unclassified (pre-2012) Terminated Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.
Sites
- Meridian Bioscience, Inc. USFEI 1524213 0 devices
From the company website
Life Discovered. Life Science Leading manufacturer of molecular and immunological reagents for diagnostic applications. Explore Life Science Life Diagnosed. Diagnostics Best-in-class diagnostic platforms, tests, education, and support to help you deliver answers. Explore Diagnostics Breaking News! Meridian Bioscience Wins the CDC’s Lead Detect Prize Competition, Building on Decades of Leadership in Blood Lead Testing at
Frequently asked questions
How many devices does Meridian Bioscience Inc. have in the registry?
The registry currently lists 246 devices for Meridian Bioscience Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Meridian Bioscience Inc.'s devices?
Among its 50 most recently registered devices, Meridian Bioscience Inc. has devices listed in EUDAMED (5 devices) and FDA GUDID (48 devices). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Meridian Bioscience Inc.'s devices fall under?
Among its 50 most recently registered devices, the classes recorded for Meridian Bioscience Inc.'s devices are Class I, Class II, Class III and IVDR Class C. Each device page shows its own class and authorisation.
Are there FDA recall records for Meridian Bioscience Inc.?
FDA recall records list 22 recalls initiated by Meridian Bioscience Inc., the most recent initiated on 5 Dec 2025. 9 of them are recorded as ongoing. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Meridian Bioscience Inc. in the registry?
The most recently registered devices listed for Meridian Bioscience Inc. include Alethia Chlamydia, alethia® Gonorrhea, StatID PRO COVID/Flu A&B Swabs 783110 and statID Pro COVID-19/Flu External Controls 783010.